Scholars Central

ArticlePublished 20 Nov 2024

Therapeutic Response Monitoring: Minimal Residual Disease Testing in Cancer Management

Authors: Shu-Ti Lin, Chen Yeh

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Clinicians are tasked with monitoring drug treatment effects to ensure safe and effective therapy. While monitoring response to treatment is vital in cancer management, reliable biomarkers for non-invasive, longitudinal, and real-time evaluations are still challenging to find. Often, monitoring is done inappropriately—too much, too little, or at the wrong time-and isn’t always targeted at clinically useful parameters. Moreover, monitoring involves more than objective laboratory tests; it requires patient participation through reporting clinical response signals. Innovative cancer research is focused on identifying biomarkers with diagnostic, prognostic, predictive, and therapeutic value. Developing accurate and robust cancer biomarkers is important for precision diagnostics and personalized treatment. These biomarkers should be used to assess therapeutic intervention efficiency, allowing early detection of therapy response, treatment failure, and disease progression or relapse. Detailed on-treatment biomarker monitoring is essential for personalized medicine. This article reviews some principles of minimal residual disease testing for therapeutic response monitoring, aiming to enhance benefits, reduce adverse events, and lower costs.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in American Journal of Physiology, Biochemistry and Pharmacology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAmerican Journal of Physiology, Biochemistry and Pharmacology
  • SubjectPharmaceutical Sciences
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Shu-Ti Lin”
  • BylineArticles whose byline prints “Chen Yeh”